Methylene Blue for Cognitive Dysfunction in Bipolar Disorder

NCT00214877 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

40

Enrollment

OTHER

Sponsor class

Conditions

Bipolar Disorder

Interventions

DRUG: Methylene Blue

Sponsor

Nova Scotia Health Authority

Collaborators

[object Object]